Table 1

Clinicopathologic characteristics of 126 patients with bladder cancer<a onClick="popup('http://www.diagnosticpathology.org/content/7/1/159/mathml/M1','MathML',630,470);return false;" target="_blank" href="http://www.diagnosticpathology.org/content/7/1/159/mathml/M1">View MathML</a>
Clinical features N (%)
Mean age (minimum-maximum) 66.8 (43–81)
Sex
Male 87 (69.0)
Female 39 (31.0)
Stage
Ta 48 (38.1)
T1 46 (36.5)
≥T2 32 (25.4)
Grade
LMP 32 (25.4)
LG 43 (34.1)
HG 51 (40.5)
Carcinoma in situ 26 (20.6)
Surgical procedure
TUR 90 (71.4)
Cystectomy 36 (28.6)
Recurrence 43 (34.1)
pTa 11 (25.6)
pT1 23 (53.5)
≥pT2 9 (20.9)
Progression 26 (18.8)
pTa 6 (23.1)
pT1 11 (42.3)
≥pT2 9 (34.6)
Death 65 (51.6)
pTa 12 (18.5)
pT1 30 (46.2)
≥pT2 23 (35.4)

TUR; transurethral resection; LMP: low malignant potential; LG: low grade; HG: high grade; Carcinoma in situ (CIS): 2 isolated CIS and 14 concomitant CIS.

Wang et al.

Wang et al. Diagnostic Pathology 2012 7:159   doi:10.1186/1746-1596-7-159

Open Data